Edition:
United Kingdom

People: Cadila Healthcare Ltd (CADI.NS)

CADI.NS on National Stock Exchange of India

323.95INR
11:29am BST
Change (% chg)

Rs-5.60 (-1.70%)
Prev Close
Rs329.55
Open
Rs329.55
Day's High
Rs331.35
Day's Low
Rs323.00
Volume
1,722,880
Avg. Vol
1,066,092
52-wk High
Rs432.50
52-wk Low
Rs305.95

Patel, Sharvil 

Dr. Sharvil P. Patel is Managing Director, Director of the Company. He was Joint Managing Director, Director of Cadila Healthcare Ltd. He is having specialization in Chemical and Pharmaceutical Sciences from University of Sunderland, U.K. and doctorate for his research work in Breast Cancer at John Hopkins, Bayview Medical Centre, USA. Dr. Patel is associated with the Company since 1997 and has contributed a lot in aligning the business and research goals of Zydus group and under his leadership jointly with the Managing Director the group has achieved sales over $1 bn in 2010-11. It is his dream to make the Company a research - based pharmaceutical company by 2020. Dr. Patel is closely associated with the Yi (Young Indians) a leadership forum initiated by the Confederation of Indian Industry which integrates young professionals from various walks of life for the developmental initiatives in the areas of economy, education, healthcare and environment. Sharvil Patel has also brought in a new dimension to the Consumer business, giving it much larger positioning in the wellness domain.

Basic Compensation

Total Annual Compensation, INR 250,000,000
Restricted Stock Award, INR --
Long-Term Incentive Plans, INR --
All Other, INR --
Fiscal Year Total, INR 250,000,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Pankaj Patel

46,000,000

Nitin Parekh

44,962,000

Ganesh Nayak

232,174,000

Sharvil Patel

250,000,000

Dhaval Soni

--

Mukesh Patel

3,800,000
As Of  31 Mar 2018